Dr. Halmai received a Master of Science from the University of Groningen in the Netherlands in Biomedical Science in 2014 and a PhD in Integrative Genetics and Genomics from UC Davis in 2020. In 2019, Dr. Halmai received the CDKL5 Junior Fellowship award from the Loulou Foundation / UPenn Orphan Disease Center for his pioneering work regarding the reactivation of silenced genes from the inactive X chromosome. Dr. Halmai is currently a postdoctoral scholar in the Fink lab at UC Davis where he continues to develop gene therapies for rare neurological conditions affecting pediatric populations. He is funded through the California Institute for Regenerative Medicine (CIRM) 2.0 postdoctoral fellowship. In 2022, Dr. Halmai received an independence award through the International Rett Syndrome Foundation to start his lab researching novel therapies for previously undruggable monogenic disorders. In addition, Dr. Halmai is the principal investigator on grants sponsored by the SMC1A foundation and UPenn Orphan Disease Center Million Dollar Bike Ride Program/ ZC4H2 research foundation to develop gene therapies for the rare X-linked disorders. His overarching research goals are to investigate the role of modulating epigenetic signatures in neurodevelopmental disease; build foundational ‘omics’ datasets and develop novel tools to advance clinical therapies for those currently suffering from untreatable childhood neurological disorders such as ARID1B related disorders.